Overview
Karaoke singers can find courage in bottles from Takara Holdings. Through its Takara Shuzo subsidiary, the company is a leading distiller of
shochu
, a traditional Japanese liquor. It also produces sake,
mirin
(a sweet cooking wine used for seasoning),
happoshu
(a low-malt beverage), and low-alcohol beverages, including fruit-based and vitamin-fortified drinks. A second subsidiary, Takara Bio, conducts
...
Read More gene research and is a leading Japanese supplier of reagents for DNA research; it also offers select pharmaceutical, nutritional, and scientific instrument products. Takara Holdings also owns health food, printing, transportation, import, engineering, and technology businesses, among others.
Read Less
Read More gene research and is a leading Japanese supplier of reagents for DNA research; it also offers select pharmaceutical, nutritional, and scientific instrument products. Takara Holdings also owns health food, printing, transportation, import, engineering, and technology businesses, among others.
Read Less
MUTSUMI KIMURA
See more contacts
Management of Companies and Enterprises
,
Holding companies, nec
?
?
?
Actual
?
Actual
$2.28 billion
Actual
-3.22%
-23.72%
$437,468
MAR
?
?
Tokyo:2531
Contacts
Get in Touch with 11 Principals*
-
MUTSUMI KIMURAPresident
-
Contact 2?
-
Contact 3?
-
Contact 4?
Dynamic search and list-building capabilities
Real-time trigger alerts
Comprehensive company profiles
Valuable research and technology reports
Financial Statements
Dun & Bradstreet collects private company financials for more than 23 million companies worldwide. Find out more.
Financial data as of March 31, 2025 (12 month period) in USD
Annual Revenue 2024
$2.28 billion
USD
Actual
1 USD = 149.1202 JPY
All financial statement data is in millions except per share data | Source: Morningstar
| Cash Flow (mil) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Net Operating Cash | $196 | $305 | $110 |
| Net Investing Cash | -$134 | -$70 | -$70 |
| Net Financing Cash | -$90 | -$149 | $28 |
| Net Change in Cash | -$29 | $86 | $68 |
| Cash at Beginning of Period | $616 | $508 | $422 |
| Cash at End of Period | $605 | $616 | $508 |
| Capital Expenditure | -$129 | -$71 | -$99 |
| Assets (mil) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Current Assets | |||
| Cash and Cash Equivalents | $638 | $649 | $539 |
| Accounts Receivable | $408 | $413 | $422 |
| Inventories | $476 | $449 | $487 |
| Other Current Assets | $122 | $108 | $110 |
| Asset Summary | |||
| Total Current Assets | $1,644 | $1,620 | $1,558 |
| Tangible Fixed Assets | $703 | $596 | $535 |
| Intangible Assets | $41 | $35 | $35 |
| Total Assets | $437,468 | $399,174 | $362,438 |
| Liabilities (mil) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Current Liabilities | |||
| Accounts Payable | $150 | $146 | $141 |
| Short-Term Debt | $101 | $33 | $104 |
| Other Current Liabilities | $291 | $273 | $286 |
| Liability Summary | |||
| Total Current Liabilities | $541 | $452 | $531 |
| Long-Term Debt | $170 | $236 | $236 |
| Other Long-Term Liabilities | $174 | $154 | $51 |
| Total Liabilities | $1,053 | $965 | $925 |
| Stakeholder's Equity (mil) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Equity | |||
| Common Stock | $89 | $89 | $89 |
| Retained Earnings | $1,139 | $1,099 | $1,005 |
| Equity Summary | |||
| Total Equity | $1,533 | $1,368 | $1,210 |
| Shares Outstanding | 195,256,355 | 197,704,743 | 197,704,743 |